Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 278 results for "orchid chemicals"

Natco Pharma Limited, Hit With A Strong Dose Of FDA Medicine

4:35 am Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug ... BioSpace, 2 days ago

Buy JM Financial, Orchid Chem; sell BOI: Krish Subramanyam

I One can buy JM Financial for a target price of Rs 46 and keep a stoploss at Rs 41.50. One can buy Orchid Chemicals for a stoploss at Rs 74. One can sell Housing Development and Infrastructure for a target price of Rs 91 and keep a stoploss at ...
 Moneycontrol.com1 week ago Orchid Chemicals & Pharmaceuticals to hold board meeting  Capital Market1 month ago Orchid Pharma to allocate shares worth Rs 92 cr to promoter group firm  Smart Investor1 month ago Buy Orchid Chemicals Ltd with a target of Rs 90: Sandeep Wagle  Economic Times2 months ago

Stocks in news: Tata Motors, Shree Cements, Fin Tech, JSPL

TCS | ONGC | Mahindra and Mahindra | Tata Motors | Hindustan Motors | Havells India | Ceat | Orchid Chemicals | Muthoot Finance | Texmaco Rail | Petronet LNG | Shree Cements | Jaiprakash Associates | Jindal Steel | MCX India and Financial Technologies are ...
 Money Control3 weeks ago Here are top 10 stocks to keep an eye on August 18  Money Control1 month ago Stocks in news: ONGC, Tata Steel, Nalco, Voltas, Lanco, MCX  Moneycontrol.com1 month ago

Exit Orchid Chemicals on rallies: Mayuresh Joshi

According to Mayuresh Joshi, VP- Institution at Angel Broking, one may exit Orchid Chemicals and Pharmaceuticals on rallies.
 Money Control1 month ago Exit Orchid Chemicals, says Kunal Saraogi  Money Control1 month ago

Orchid Chemicals net loss increases to Rs.60 cr in Q3

Orchid Chemicals and Pharmaceuticals has suffered setback during the third quarter ended June 2014 and its net loss increased to Rs. 60.14 crore from Rs. 54.50 crore in the corresponding period of last year despite net sales growth of 12.1 per cent ...
 PharmaBiz1 month ago Orchid Chemicals & Pharmaceuticals reports net loss of Rs 60.14 crore in the June 2014 quarter  Business Standard1 month ago Orchid Pharma registers turnover of Rs 285 crore in Q3 FY14  Noodls1 month ago

Pharma stocks outperform equity benchmarks, rally 2-14%

Marksans Pharma surged 7 percent (up 200 percent year-to-date) while Orchid Chemicals gained 9 percent as it expects to increase capacity utilisation to 90-100 percent by end of this year.
 Money Control1 month ago

New Report Available: Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014

Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014', provides an overview of the Orchid Chemicals & Pharmaceuticals ...
 Town Hall3 weeks ago New Market Research Report: Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014  Town Hall3 weeks ago New Report Available Orchid ChemicalsPharmaceuticals Ltd - Product Pipeline Review - 2014  MENAFN3 weeks ago Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014  Town Hall1 month ago
[x]  

07.15.14 -- Lilly and Yabao To Partner For Diabetes Therapy; Hospira Acquires Orchid

SPONSOR Outsourced Pharma West Conference And Exhibition November 10 and 11, 2014 | Hyatt Regency, San Francisco, CA • Who should attend? Pharma and biopharm executives who form and manage outsourcing partnerships. ...
 Pharmaceutical Online2 months ago Orchid Chem hits 52-wk high, up 3%; seals deal with Hospira  Money Control2 months ago Orchid completes Hospira deal, implementation of CDR package  Business Standard2 months ago Hospira complets acquisition of Orchid Pharma's facilities  Business Standard2 months ago

Hospira Upgraded to Strong Buy on Orchid Facility Buy

On Jul 12, Zacks Investment Research upgraded Hospira Inc. ( HSP ) to a Zacks #1 Rank (Strong Buy). Why the Upgrade? The upgrade came on the heels of Hospira's recently completed Orchid facility buy. Earlier in the month, the company announced ...
 Yahoo! Finance2 months ago

Orchid Island Capital (ORC) Tops Q2 EPS Views

We provide value to our customers by gathering, confirming, updating and disseminating information about industrial plants and their spending activities around the world so they can make timely and intelligent business decisions. Learn more about ...
 Industrial Info Financials1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less